PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany
Abstract
Authors
Y. Jiang A. Gauthier L. Annemans M. van der Linden L. Nicolas-Spony X. Bresse